These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 10612798)
41. Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation. Zheng H; Chang L; Patel N; Yang J; Lowe L; Burns DK; Zhu Y Cancer Cell; 2008 Feb; 13(2):117-28. PubMed ID: 18242512 [TBL] [Abstract][Full Text] [Related]
42. Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with type 1 neurofibromatosis. Badache A; Muja N; De Vries GH Oncogene; 1998 Aug; 17(6):795-800. PubMed ID: 9715282 [TBL] [Abstract][Full Text] [Related]
43. Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas. Overdiek A; Feifel H; Schaper J; Mayatepek E; Rosenbaum T Brain Dev; 2006 Jun; 28(5):275-80. PubMed ID: 16481142 [TBL] [Abstract][Full Text] [Related]
44. Methylation analysis of the neurofibromatosis type 1 (NF1) promoter in peripheral nerve sheath tumours. Harder A; Rosche M; Reuss DE; Holtkamp N; Uhlmann K; Friedrich R; Mautner VF; von Deimling A Eur J Cancer; 2004 Dec; 40(18):2820-8. PubMed ID: 15571966 [TBL] [Abstract][Full Text] [Related]
45. Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells. Li H; Zhang X; Fishbein L; Kweh F; Campbell-Thompson M; Perrin GQ; Muir D; Wallace M Cancer Biol Ther; 2010 Oct; 10(8):758-64. PubMed ID: 20699653 [TBL] [Abstract][Full Text] [Related]
46. Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system. Brossier NM; Carroll SL Brain Res Bull; 2012 May; 88(1):58-71. PubMed ID: 21855613 [TBL] [Abstract][Full Text] [Related]
47. MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis. Masliah-Planchon J; Pasmant E; Luscan A; Laurendeau I; Ortonne N; Hivelin M; Varin J; Valeyrie-Allanore L; Dumaine V; Lantieri L; Leroy K; Parfait B; Wolkenstein P; Vidaud M; Vidaud D; Bièche I BMC Genomics; 2013 Jul; 14():473. PubMed ID: 23848554 [TBL] [Abstract][Full Text] [Related]
48. Nestin-positive stem cells in neurofibromas from patients with neurofibromatosis type 1-tumorigenic or incidental? Pongpudpunth M; Bhawan J; Al-Natour SH; Mahalingam M Am J Dermatopathol; 2010 Aug; 32(6):574-7. PubMed ID: 20520523 [TBL] [Abstract][Full Text] [Related]
56. Is the distribution of dermal neurofibromas in neurofibromatosis type 1 (NF1) related to the pattern of the skin surface temperature? Kaufmann D; Tinschert S; Algermissen B Eur J Dermatol; 2001; 11(6):521-6. PubMed ID: 11701400 [TBL] [Abstract][Full Text] [Related]
57. Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors. I. The role of tumor suppressor mutations. Carroll SL; Stonecypher MS J Neuropathol Exp Neurol; 2004 Nov; 63(11):1115-23. PubMed ID: 15581179 [TBL] [Abstract][Full Text] [Related]
58. Influence of hormones and hormone metabolites on the growth of Schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin. Roth TM; Ramamurthy P; Muir D; Wallace MR; Zhu Y; Chang L; Barald KF Dev Dyn; 2008 Feb; 237(2):513-24. PubMed ID: 18213578 [TBL] [Abstract][Full Text] [Related]